Brii Biosciences
IPO
To tackle public health challenges through breakthrough scientific innovation and critical patient insights
- Headquarters
- San Francisco Bay Area, California
- Employees
- 51–200
- Founded
- 2018
- Business Model
- Other
- Website
- briibio.com
- Total Funding
- $865.0M
- Last Round
- $450.0M Venture RoundMay 2025
About
Brii Biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases and central nervous system diseases, the company has built a robust pipeline based on patient insights.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account